effect overlay
activetrials
Stroke
Stroke
MIDAS2

Modafinil in Debilitating fatigue After Stroke 2(MIDAS2): A Phase ll, Multicentre, Prospective, Randomised, Placebo-controlled, Double-Blind, Parallel group with an adaptive sample size re-estimation study in Stroke Survivors
 

HREC: 2018.125
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Amy McDonald
Funding: Non-Commercial
Stroke
Stroke
MSU Implementation Evaluation

Melbourne Mobile Stroke Unit (MSU) Implementation Program Evaluation including Cost-Effectiveness
 

HREC: 2017.456
Principal Investigator: Dr Henry Zhao
Coordinator contact:
Funding: Non-Commercial
Stroke
Stroke
BRISK Registry

The Biomarker Research in StroKe (BRISK) Registry
 

HREC: 2017.005
Principal Investigator: Prof Bernard Yan
Coordinator contact: Laura Fisicchia
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
B-cell Repopulation

B-cell repopulation in patients with multiple sclerosis treated with anti-CD20 therapies
 

HREC: 2023.079
Principal Investigator: Prof Tomas Kalincik
Coordinator contact:
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
SARS-CoV2 antibody-seroprevalence in MS

SARS-CoV2 antibody-seroprevalence in patients with multiple sclerosis
 

HREC: 2020.305
Principal Investigator: Dr Chris Dwyer
Coordinator contact:
Funding: Non-Commercial